Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Crohn'S & Colitis
|
February 24, 2018
Infliximab as Rescue Treatment in Sweet's Syndrome Related to Corticodependent Ulcerative Colitis
C Moreno Márquez, B Maldonado Pérez, L Castro Laria
Revista Clinica Espanola
|
June 17, 2000
[Abdominal tumor and fever]
J M Martín Guerrero, L Castro Laria, M D Martín Salvago, et al.
Gastroenterologia Y Hepatologia
|
October 27, 1999
[Usefulness of echography in the diagnosis of biliary ileus]
B J Gomez Rodriguez, D Ledro Cano, L Castro Laria, et al.
Revista Espanola De Enfermedades Digestivas
|
January 4, 2001
Biochemical markers and bone densitometry in inflammatory bowel disease
D Ledro Cano, Y Torres Domínguez, L Castro Laria, et al.
Revista Espanola De Enfermedades Digestivas
|
July 9, 2011
Efficacy of adalimumab in patients with Crohn's disease and failure to infliximab therapy: a clinical series
P Cordero Ruiz, C Castro Márquez, V Méndez Rufián, et al.
Revista Espanola De Enfermedades Digestivas
|
December 29, 1998
[Usefulness of ultrasonography in the diagnosis of portal hypertension]
F J Fernández Pérez, J M García Montes, L Castro Laria, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
September 13, 2018
Does the Antitumor Necrosis Factor-α Therapy Decrease the Vertebral Fractures Occurrence in Inflammatory Bowel Disease?
M B Maldonado-Pérez, L Castro-Laria, A Caunedo-Álvarez, et al.
Digestive Diseases and Sciences
|
June 30, 2017
Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months
F Argüelles-Arias, M F Guerra Veloz, R Perea Amarillo, et al.
Digestive Diseases and Sciences
|
March 11, 2017
Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months
F Argüelles-Arias, M F Guerra Veloz, R Perea Amarillo, et al.
Digestive Diseases and Sciences
|
July 6, 2013
Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease
F Argüelles-Arias, L Castro-Laria, T Lobatón, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Crohn'S & Colitis
|
February 24, 2018
Infliximab as Rescue Treatment in Sweet's Syndrome Related to Corticodependent Ulcerative Colitis
C Moreno Márquez, B Maldonado Pérez, L Castro Laria
Revista Clinica Espanola
|
June 17, 2000
[Abdominal tumor and fever]
J M Martín Guerrero, L Castro Laria, M D Martín Salvago, et al.
Gastroenterologia Y Hepatologia
|
October 27, 1999
[Usefulness of echography in the diagnosis of biliary ileus]
B J Gomez Rodriguez, D Ledro Cano, L Castro Laria, et al.
Revista Espanola De Enfermedades Digestivas
|
January 4, 2001
Biochemical markers and bone densitometry in inflammatory bowel disease
D Ledro Cano, Y Torres Domínguez, L Castro Laria, et al.
Revista Espanola De Enfermedades Digestivas
|
July 9, 2011
Efficacy of adalimumab in patients with Crohn's disease and failure to infliximab therapy: a clinical series
P Cordero Ruiz, C Castro Márquez, V Méndez Rufián, et al.
Revista Espanola De Enfermedades Digestivas
|
December 29, 1998
[Usefulness of ultrasonography in the diagnosis of portal hypertension]
F J Fernández Pérez, J M García Montes, L Castro Laria, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
September 13, 2018
Does the Antitumor Necrosis Factor-α Therapy Decrease the Vertebral Fractures Occurrence in Inflammatory Bowel Disease?
M B Maldonado-Pérez, L Castro-Laria, A Caunedo-Álvarez, et al.
Digestive Diseases and Sciences
|
June 30, 2017
Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months
F Argüelles-Arias, M F Guerra Veloz, R Perea Amarillo, et al.
Digestive Diseases and Sciences
|
March 11, 2017
Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months
F Argüelles-Arias, M F Guerra Veloz, R Perea Amarillo, et al.
Digestive Diseases and Sciences
|
July 6, 2013
Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease
F Argüelles-Arias, L Castro-Laria, T Lobatón, et al.
Page
of 2